The 1995 WHO Cocaine Project: What the Dispute Actually Shows

The descriptive project and its qualifications

Between 1992 and 1994, researchers working on the WHO/UNICRI Cocaine Project gathered information from 22 cities in 19 countries.^[1] Their March 1995 briefing described considerable variation in patterns of use and associated problems. It also discussed traditional coca-leaf use, which should not be collapsed into the use of refined cocaine.

The briefing explicitly said that its conclusions represented participating researchers rather than official WHO recommendations.^[1] Its covering statement warned against reading the material as an endorsement of psychoactive substances. Extracting a reassuring sentence while discarding those qualifications changes the meaning of the document.

The project combined country profiles, key-informant reports and a smaller natural-history component.^[1] Its strength was describing variation across social settings. It was not a clinical experiment assigning people to take cocaine, and its discussion of different patterns of use cannot establish a guaranteed level of individual safety.

The funding threat at the World Health Assembly

Political opposition is documented in the official summary record of the Forty-eighth World Health Assembly. The United States representative, Mr Boyer, objected that the press package seemed to promote positive uses of coca and undermine international drug-control efforts.^[2] He said funding for relevant programmes should be curtailed if WHO’s work failed to reinforce the approaches his government supported.^[2]

The assembly exchange reveals how publication and policy became entangled. Boyer disputed the apparent message of the press material; Piel distinguished researchers' analysis from the organization's recommendations. Those were separate disputes over evidence, presentation and institutional endorsement, even though the threat to programme funding brought them into the same conversation.

Publication, policy and the surviving record

WHO representative Dr Piel defended the project as an objective analysis while distinguishing it from WHO policy.^[2] He said the organization did not intend to publish the report in that form because its wording could cause misunderstanding.^[2] Boyer challenged the research standards and sought peer review; Piel said that option would be considered.^[2]

The briefing's survival also matters. Readers can inspect the researchers' qualifications and compare them with the official meeting record. The existence of that accessible record is incompatible with the strongest claim that all copies were formally prohibited. The narrower history concerns pressure over a publication's form and authority.

The record supports a specific conclusion: a major funder applied public pressure, and WHO described a decision against publication in the proposed form. It does not record a formal assembly vote banning all copies of the research. Nor does it turn a 1990s descriptive study into current medical advice. The episode is about the relationship between research, institutional policy, and political power—not evidence that the risks of cocaine disappeared.